Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives.
So keep plugging away. After all, what are the alternatives?
While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is maple cinnamon French toast.
Remember that no prescription is required — so no co-pay or rebate is involved. Meanwhile, here is the latest menu of tidbits to help you on your way.
Have a wonderful day and please do stay in touch. … The Trump administration had planned for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot program, but insurers said no, so the government will instead cover the drugs outside of the Medicare Part D drug benefit , STAT explains.
Last year, the Trump administration struck a deal with Eli Lilly and Novo Nordisk to lower the prices of their popular obesity drugs in exchange for expanding access to those drugs in Medicare and Medicaid.
STAT News published a clinical update in Research Highlights on 22 Apr 2026.
The item focuses on STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more.
Review the original article for the full source wording and details.